REGN vs STRT · P/E 14, rev $14.34B vs P/E 13, rev $565.1M
Regeneron Pharmaceuticals Inc (REGN) versus Strattec Security Corporation (STRT) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Strattec Security Corporation (STRT) is a auto parts company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported STRT revenue for 2025-06-29 was $565.1M. Net income was $18.9M. Revenue was up 5.1% from 2024-06-30 to 2025-06-29. STRT currently screens at market cap $323.9M and trailing P/E 12.8.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. STRT currently screens at market cap $323.9M and trailing P/E 12.8.
Not investment advice. Open the REGN and STRT stock pages for the full models.
Not investment advice.